Multiple Assemblies exist for SMTL entry 2plv
STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS; X-RAY DIFFRACTION 2.88 Å

	SMTL ID 2plv.1 Ligands SPHINGOSINE; MYRISTIC ACID Polypeptides HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP1); HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP2); HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP3); HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP4) Oligo-state hetero-1-1-1-1-mer
	SMTL ID 2plv.2 Ligands SPHINGOSINE; MYRISTIC ACID Polypeptides HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP1); HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP2); HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP3); HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP4) Oligo-state hetero-5-5-5-5-mer
	SMTL ID 2plv.3 Ligands SPHINGOSINE; MYRISTIC ACID Polypeptides HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP1); HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP2); HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP3); HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP4) Oligo-state hetero-6-6-6-6-mer
	SMTL ID 2plv.4 Ligands SPHINGOSINE; MYRISTIC ACID Polypeptides HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP1); HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP2); HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP3); HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP4) Oligo-state hetero-1-1-1-1-mer